These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 30761303)
61. Elements of renal injury in patients with erysipelas. Velciov S; Gluhovschi G; Feier V; Curescu M; Trandafirescu V; Petrică L; Gluhovschi C; Bob F; Bozdog G; Gadalean F; Florescu C; Bobu M; Chiliban A Rom J Intern Med; 2010; 48(2):179-85. PubMed ID: 21428183 [TBL] [Abstract][Full Text] [Related]
62. Antibiotic use in patients with erysipelas: a retrospective study. Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544 [TBL] [Abstract][Full Text] [Related]
63. Recurrent erysipelas--risk factors and clinical presentation. Inghammar M; Rasmussen M; Linder A BMC Infect Dis; 2014 May; 14():270. PubMed ID: 24884840 [TBL] [Abstract][Full Text] [Related]
64. Frequency of symptomatic relapses of group A beta-hemolytic streptococcal tonsillopharyngitis in children from 4 pediatric practices following penicillin, amoxicillin, and cephalosporin antibiotic treatment. Casey JR; Kahn R; Gmoser D; Atlas E; Urbani K; Luber S; Pellman H; Pichichero ME Clin Pediatr (Phila); 2008 Jul; 47(6):549-54. PubMed ID: 18490665 [TBL] [Abstract][Full Text] [Related]
66. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Pichichero ME Ann Emerg Med; 1995 Mar; 25(3):390-403. PubMed ID: 7864482 [TBL] [Abstract][Full Text] [Related]
67. Strategies for managing group A streptococcal pharyngitis. A survey of board-certified pediatricians. Hofer C; Binns HJ; Tanz RR Arch Pediatr Adolesc Med; 1997 Aug; 151(8):824-9. PubMed ID: 9265886 [TBL] [Abstract][Full Text] [Related]
69. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli. Ejrnæs K Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767 [TBL] [Abstract][Full Text] [Related]
72. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas. Ferreira A; Bolland MJ; Thomas MG Infection; 2016 Oct; 44(5):607-15. PubMed ID: 27085865 [TBL] [Abstract][Full Text] [Related]
73. Factors associated with acute and recurrent erysipelas in a young population: a retrospective of 147 cases. Chamli A; Jaber K; Ben Lagha I; Ben Slimane M; Rabhi F; Doss N; Dhaoui MR Tunis Med; 2021 Aout; 99(8):886-889. PubMed ID: 35261016 [TBL] [Abstract][Full Text] [Related]
74. Antibiotic prophylaxis for preventing recurrent cellulitis: a systematic review and meta-analysis. Oh CC; Ko HC; Lee HY; Safdar N; Maki DG; Chlebicki MP J Infect; 2014 Jul; 69(1):26-34. PubMed ID: 24576824 [TBL] [Abstract][Full Text] [Related]